{
    "clinical_study": {
        "@rank": "68801", 
        "arm_group": {
            "arm_group_label": "FlowOx", 
            "arm_group_type": "Experimental", 
            "description": "5 minutes of pulsating negative pressure (10 sek og -40mmHg/7 sek of athmospheric pressure) will be Applied to the patient's leg"
        }, 
        "brief_summary": {
            "textblock": "A study to assess the effect of negative pulsating pressure therapy on patients with\n      impaired blood flow to the leg caused by arterial disease, to see if the FlowOx device will\n      increase the blood flow to the leg in these patients."
        }, 
        "brief_title": "Effect on Blood Flow Using the FlowOx\u2122 Device in Patients With Reduced Peripheral Circulation in the Lower Leg", 
        "completion_date": {
            "#text": "December 2013", 
            "@type": "Anticipated"
        }, 
        "condition": "Periferal Arterial Occlusive Disease, PAOD", 
        "condition_browse": {
            "mesh_term": "Arterial Occlusive Diseases"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Written Informed Consent\n\n          -  Age 30-90 years\n\n          -  Affected foot/shoe sise less than 46 (approximate foot length less than 29.5 cm)\n\n          -  Patients with Peripheral Arterial Occlusive Disease (PAOD) grade 2,3 or 4, i.e.:\n\n               1. Clinically verified grade 2, i.e. Intermittent Claudication:\n\n                    -  Ancle-Brachial Index (ABI)less than 0.9 or\n\n                    -  Toe brachial Index (TBI) less than 0.7 or\n\n                    -  Ultrasound and/or CT/Magnetic Resonance (MR) angiography suggesting\n                       stenosis(es)and/or occlusion(s)\n\n               2. Clinically verified grade 3, i.e. Critical Limb Ischemia (CLI):\n\n                    -  ABI less than 0.4 or\n\n                    -  Toe pressure less than 30 mmHg\n\n                    -  Rest pain since at least 2 weeks or\n\n                    -  Use of analgesics for rest pain for at least 2 weeks or\n\n                    -  Ultrasound and/or CT/Magnetic Resonance (MR) angiography suggesting\n                       stenosis(es)and/or occlusion(s)\n\n               3. Clinically verified grade 4, i.e. CLI:\n\n                    -  Ischemic ulcers or gangrene/tissue loss\n\n                    -  ABI less than 0.4\n\n                    -  Toe pressure less than 30 mmHg\n\n                    -  Rest pain since at least 2 weeks or\n\n                    -  Use of analgesics for rest pain for at least 2 weeks or\n\n                    -  Ultrasound and/or CT/MR angiography suggesting stenosis(es)and/or\n                       occlusion(s)\n\n        Exclusion Criteria:\n\n          -  Grade 1 PAOD\n\n          -  Incapable of consenting voluntarily\n\n          -  Fewer higher than 39 degrees Centigrade\n\n          -  Severe Chronic Obstructive Pulmonary Disease (COPD)\n\n          -  Severe heart disease such as unstable angina, severe heart failure and severe valve\n             failure\n\n          -  Severe Polyneurophathy\n\n          -  Verified Osteomyelitis other than in the Phanlanx\n\n          -  Currently treated for cancer and With a life expectancy of less than 2 years"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "90 Years", 
            "minimum_age": "30 Years"
        }, 
        "enrollment": {
            "#text": "20", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "June 26, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01893840", 
            "org_study_id": "OT-FO-01"
        }, 
        "intervention": {
            "arm_group_label": "FlowOx", 
            "description": "Boot-shaped pressure chamber generating pulsating negative pressure", 
            "intervention_name": "FlowOx", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "October 30, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "L\u00f8renskog", 
                    "country": "Norway", 
                    "zip": "N-1478"
                }, 
                "name": "Akershus University Hospital"
            }
        }, 
        "location_countries": {
            "country": "Norway"
        }, 
        "number_of_arms": "1", 
        "official_title": "Effect on Blood Flow Using the FlowOx\u2122 Device in Patients With Reduced Peripheral Circulation in the Lower Leg", 
        "other_outcome": {
            "measure": "Fitting time", 
            "safety_issue": "No", 
            "time_frame": "up to 1 hour"
        }, 
        "overall_official": {
            "affiliation": "Principal Investigator", 
            "last_name": "Jarlis Wesche, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "Norway: Directorate of Health", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "This is calculated as the difference between the blood flow during the period using FlowOx\u2122 (middle value over a period of 5 minutes) and baseline blood flow (middle value over a period of 5 prior to using FlowOx\u2122)", 
            "measure": "% of the prescribed cycles delivered in the specified time   FlowOx\u2122-induced change in arterial leg blood flow (LBF)", 
            "safety_issue": "No", 
            "time_frame": "up to 1 hour"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01893840"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "measure": "Patient comfort measured by asking the patient a fixed set of questions", 
            "safety_issue": "No", 
            "time_frame": "up to 1 hour"
        }, 
        "source": "Otivio AS", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "European Union", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "The Research Council of Norway", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "Otivio AS", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "August 2013", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label", 
        "study_type": "Interventional", 
        "verification_date": "October 2013"
    }
}